- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
NxStage Medical Inc
+ Add to WatchlistNXTM:US
13.7400 USD 0.2300 1.70%As of 20:10:00 ET on 05/22/2013.
Snapshot for NxStage Medical Inc (NXTM)
| Open: | 13.4900 | Day's Range: | 13.4900 - 13.8300 | Volume: | 625,908 |
|---|---|---|---|---|---|
| Previous Close: | 13.7400 | 52wk Range: | 10.1500 - 17.1500 | 1-Yr Rtn: | -8.64% |
Key Statistics for NXTM
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.2500 |
| Est. EPS (USD) (12/2013) | -0.2530 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 820.78 |
| Shares Outstanding (M) | 59.74 |
| 30 Day Average Volume | 309,907 |
| Price/Book (mrq) | 4.1699 |
| Price/Sale (ttm) | 3.2728 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/08/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for NXTM
Company Profile & Key Executives for NXTM
NxStage Medical, Inc. is medical device company that develops, manufactures, and markets systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. The Company's primary product, the NxStage System One, is a small, portable hemodialysis system.
| Jeffrey H Burbank "Jeff"President/CEO/Founder | Joseph E Turk Jr "Joe"Pres:North American Ops |
| Robert S BrownSenior VP/CFO/Treasurer | Winifred L SwanSenior VP/Secy/General Counsel |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
NXTM News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page